Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 85
  • Shares Outstanding, K 1,135
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,630 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 3.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.01
  • Most Recent Earnings $-2.48 on 03/27/24
  • Next Earnings Date 11/26/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0010 +7,410.00%
on 11/20/24
0.0751 unch
on 11/22/24
+0.0729 (+3,313.64%)
since 10/22/24
3-Month
0.0004 +18,675.00%
on 10/15/24
0.0751 unch
on 11/22/24
+0.0725 (+2,788.46%)
since 08/22/24
52-Week
0.0001 +75,000.00%
on 07/31/24
7.4700 -98.99%
on 11/30/23
-2.0349 (-96.44%)
since 11/22/23

Most Recent Stories

More News
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a...

AMPE : 0.0751 (+651.00%)
Ampio Pharmaceuticals to Present at the Emerging Growth Conference

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") a pre-revenue stage biopharmaceutical Company focused on development of a...

AMPE : 0.0751 (+651.00%)
Ampio Pharmaceuticals Announces Reverse Stock Split

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors has approved a 20-to-1 reverse...

AMPE : 0.0751 (+651.00%)
Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors declared a dividend of one...

AMPE : 0.0751 (+651.00%)
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin...

AMPE : 0.0751 (+651.00%)
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin...

AMPE : 0.0751 (+651.00%)
Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that it has received notification from The NYSE American LLC...

AMPE : 0.0751 (+651.00%)
AMPIO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”)...

AMPE : 0.0751 (+651.00%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

The Law Offices of Frank R. Cruz reminds investors of the upcoming October 17, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ampio Pharmaceuticals,...

AMPE : 0.0751 (+651.00%)

Business Summary

Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products offered by the Company include Optina, an oral drug for the treatment of diabetic retinopathy and macular edema; and Vasaloc,...

See More

Key Turning Points

3rd Resistance Point 0.0751
2nd Resistance Point 0.0751
1st Resistance Point 0.0751
Last Price 0.0751
1st Support Level 0.0751
2nd Support Level 0.0751
3rd Support Level 0.0751

See More

52-Week High 7.4700
Fibonacci 61.8% 4.6165
Fibonacci 50% 3.7350
Fibonacci 38.2% 2.8536
Last Price 0.0751
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar